Clinical Trial: Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women

U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06997653) titled 'Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women' on March 09, 2022.

Brief Summary: This study is an open-label and Phase 2b clinical trial of the COVID-19 inactivated TURKOVAC vaccine against SARS-CoV-2 in healthy pregnant women.

Study Start Date: Jan. 01, 2024

Study Type: INTERVENTIONAL

Condition: COVID-19 SARS CoV 2 Infection

Intervention: BIOLOGICAL: TURKOVAC

Inactive COVID-19 Vaccine - TURKOVAC

Recruitment Status: WITHDRAWN

Sponsor: Health Institutes of Turkey

Disclaimer: Curated by HT Syndication....